Q-Line Biotec SME IPO GMP Today
The Q-Line Biotec SME IPO closed on 25 May 2026. Q-Line Biotec SME IPO GMP is Rs 129.00 today. Listing price estimate is Rs 472.00 (issue price Rs 343.00). Listing gain estimate: 37.61%.
Issue Price
Rs 343.00
GMP Today
Rs 129.00
GMP %
+37.61%
Listing Price
Rs 472.00
Listing Gain / Lot
Rs 1,03,200.00
Listing Date
29 May 2026
Q-Line Biotec SME IPO GMP Day Wise
GMP for Q-Line Biotec SME started at Rs 0 on 17 May 2026 and stood at Rs 133 on 29 May 2026. The sharpest single-day jump was from Rs 0 on 17 May 2026 to Rs 69 on 18 May 2026. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 29 May 2026Today | Rs 343.00 | Rs 133.00 | Rs 476.00 (+38.78%) | Rs 1,06,400.00 |
| 28 May 2026 | Rs 343.00 | Rs 129.00 | Rs 472.00 (+37.61%) | Rs 1,03,200.00 |
| 27 May 2026 | Rs 343.00 | Rs 124.00 | Rs 467.00 (+36.15%) | Rs 99,200.00 |
| 26 May 2026 | Rs 343.00 | Rs 108.00 | Rs 451.00 (+31.49%) | Rs 86,400.00 |
| 25 May 2026 | Rs 343.00 | Rs 101.00 | Rs 444.00 (+29.45%) | Rs 80,800.00 |
| 24 May 2026 | Rs 343.00 | Rs 125.00 | Rs 468.00 (+36.44%) | Rs 1,00,000.00 |
| 23 May 2026 | Rs 343.00 | Rs 127.00 | Rs 470.00 (+37.03%) | Rs 1,01,600.00 |
| 22 May 2026 | Rs 343.00 | Rs 127.00 | Rs 470.00 (+37.03%) | Rs 1,01,600.00 |
| 21 May 2026 | Rs 343.00 | Rs 117.00 | Rs 460.00 (+34.11%) | Rs 93,600.00 |
| 20 May 2026 | Rs 343.00 | Rs 141.00 | Rs 484.00 (+41.11%) | Rs 1,12,800.00 |
| 19 May 2026 | Rs 343.00 | Rs 110.00 | Rs 453.00 (+32.07%) | Rs 88,000.00 |
| 18 May 2026 | Rs 343.00 | Rs 69.00 | Rs 412.00 (+20.12%) | Rs 55,200.00 |
| 17 May 2026 | Rs 343.00 | Rs 0.00 | Rs 343.00 (+0.00%) | Rs 0.00 |
Q-Line Biotec SME IPO Listing Price
Based on today's GMP, Q-Line Biotec SME IPO listing price estimate is Rs 472.00 per share (issue price Rs 343.00 + GMP Rs 129.00).
Actual listing price will be known on 29 May 2026 when the stock lists on NSE/BSE.
Q-Line Biotec SME IPO Listing Gain
Lot size: 400 shares (min. 2 lots for SME)
GMP today: Rs 129.00
Estimated listing gain per lot: Rs 129.00 × 800 = Rs 1,03,200.00
A GMP of around 37.6% is a strong positive signal from the grey market. Investors are pricing in a meaningful listing premium over the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
Q-Line Biotec SME IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. The GMP move around 18 May 2026 may reflect how the market reacted once the subscription window activity picked up after 21 May 2026.
See live figures on the Q-Line Biotec SME IPO Subscription Status page.
Q-Line Biotec SME IPO Details
| Field | Value |
|---|---|
| Price Band | ₹326.0 - ₹343.0 |
| Issue Size | ₹214.48 Cr |
| Lot Size | 400 shares |
| IPO Type | NSE SME |
| Open Date | 21 May 2026 |
| Close Date | 25 May 2026 |
| Listing Date | 29 May 2026 |
| Subscription | 0x |
Q-Line Biotec SME IPO full details (financials, peers, review).
About Q-Line Biotec SME
Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing, manufacturing, and marketing a diverse range of medical reagents, consumable testing kits, point-of-care (POC) devices, and automated pathology equipment. Serving diagnostic laboratories, hospitals, and medical colleges directly and through an expansive national distributor network since 2013, its operational capabilities span fields like Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
Q-Line Biotec SME IPO GMP FAQs
What is the current GMP for Q-Line Biotec SME?
The current GMP for Q-Line Biotec SME is Rs 129 as of 11 June 2026, 5:17 AM IST. This is a premium of 37.61% over the issue price of Rs 343.
What is the estimated listing price based on current GMP?
The estimated listing price is Rs 472 per share, calculated as issue price (Rs 343) plus GMP (Rs 129). Actual listing price will be confirmed on 29 May 2026.
Will Q-Line Biotec SME IPO list at the GMP price?
Q-Line Biotec SME IPO may list around Rs 472 based on current GMP of Rs 129, but there is no guarantee it will list exactly at the grey market price. GMP is unofficial. The actual listing price on 29 May 2026 depends on market sentiment, subscription demand, and broader index levels on listing day. When subscription is strong and GMP holds steady after the IPO closes, listing price often comes close to the GMP estimate. Sharp GMP drops after subscription close have led to listings below the grey market price in the past.
What is the estimated profit per lot based on GMP?
At GMP of Rs 129 and lot size of 400 shares (minimum 2 lots for SME), estimated grey market profit is Rs 1,03,200 (2 lots x 400 shares x Rs 129). This is unofficial and not guaranteed.
What is GMP (Grey Market Premium)?
GMP is the premium at which IPO shares trade in the unofficial grey market before listing on NSE or BSE. It reflects informal demand and sentiment, not an exchange-set price.
How is GMP calculated?
Estimated listing price = issue price + GMP. GMP percentage = (GMP / issue price) x 100. Estimated profit per lot = GMP x lot size x minimum lots (2 for SME, 1 for mainboard).
Is GMP reliable for IPO investment decisions?
GMP is a sentiment indicator. Use it with subscription data, financials, valuation, and market conditions. It does not guarantee listing price or listing day gains.
Can GMP change before listing?
Yes. GMP can change between the close date (25 May 2026) and listing date (29 May 2026) based on market mood, news, and broader index movement.
What happens if GMP is negative?
Negative GMP suggests weak informal demand and possible listing below issue price. Actual listing may still differ.
How does GMP affect IPO subscription?
Rising GMP can attract more applications in the final hours of subscription. High GMP with weak fundamentals has still led to poor listings, so read subscription category-wise before applying.
Where can I track Q-Line Biotec SME subscription and allotment?
Check Q-Line Biotec SME IPO subscription status on IPOwiz for live category-wise bids. Allotment status can be checked from the allotment date on the IPOwiz allotment page.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. GMP verified before publish.